Prolia
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Prolia in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Prolia.
38
Global Revenue Ranking
Recent articles on PMLiVE featuring Prolia
The drug is approved for inflammatory conditions such as Crohn’s disease and plaque psoriasis
The drugs have been authorised for all indications covered by Amgen’s bone disease therapy
Osteoporosis, which particularly impacts older women after menopause, currently affects 3.8 million people in the UK
The drug has been authorised to treat plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis
The biosimilars have been authorised for all indications covered by Amgen’s reference medicines
More than ten million adults in the US alone over the age of 50 are estimated to have the condition
First new drug for the disease in the EU since 2010
Move has resulted in loss of around 180 jobs
Initially received a negative opinion of the drug
Another obstacle for drug
Drug unlikely to match Prolia’s revenues
US drugs regulator first rejected the drug due to cardiovascular concerns
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology